BSE Live
Dec 12, 16:01Prev. Close
3801.20
Open Price
3751.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 12, 15:52Prev. Close
3799.00
Open Price
3801.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3791.50 (172)
| Balance Sheet of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 84.62 | 84.62 | 42.31 | 42.31 | 42.31 | |
| Total Share Capital | 84.62 | 84.62 | 42.31 | 42.31 | 42.31 | |
| Reserves and Surplus | 2,620.97 | 2,205.19 | 1,608.78 | 1,262.18 | 1,050.74 | |
| Total Reserves and Surplus | 2,620.97 | 2,205.19 | 1,608.78 | 1,262.18 | 1,050.74 | |
| Total Shareholders Funds | 2,705.59 | 2,289.81 | 1,651.09 | 1,304.49 | 1,093.05 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 2,185.22 | 744.46 | 454.54 | 322.06 | 293.04 | |
| Deferred Tax Liabilities [Net] | 188.84 | 47.46 | 56.89 | 63.17 | 61.71 | |
| Other Long Term Liabilities | 6.94 | 9.61 | 9.76 | 0.45 | 0.32 | |
| Long Term Provisions | 97.12 | 74.40 | 71.01 | 59.65 | 20.72 | |
| Total Non-Current Liabilities | 2,478.12 | 875.93 | 592.20 | 445.32 | 375.78 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 100.00 | 210.34 | 124.62 | 138.12 | 99.57 | |
| Trade Payables | 630.23 | 479.69 | 449.69 | 373.40 | 298.95 | |
| Other Current Liabilities | 426.39 | 337.72 | 329.87 | 257.38 | 269.99 | |
| Short Term Provisions | 169.26 | 139.19 | 207.84 | 59.67 | 84.41 | |
| Total Current Liabilities | 1,325.88 | 1,166.94 | 1,112.02 | 828.57 | 752.91 | |
| Total Capital And Liabilities | 6,509.59 | 4,332.68 | 3,355.31 | 2,578.38 | 2,221.74 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 905.31 | 831.39 | 784.99 | 628.59 | 581.09 | |
| Intangible Assets | 1,858.19 | 4.77 | 6.39 | 7.71 | 6.52 | |
| Capital Work-In-Progress | 627.78 | 507.58 | 276.31 | 26.87 | 44.37 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 3,391.28 | 1,343.74 | 1,067.69 | 663.17 | 631.98 | |
| Non-Current Investments | 150.35 | 149.38 | 147.50 | 391.30 | 304.53 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 186.05 | 106.49 | 53.36 | 53.67 | 37.14 | |
| Other Non-Current Assets | 50.28 | 60.74 | 23.90 | 46.25 | 46.34 | |
| Total Non-Current Assets | 3,777.96 | 1,660.35 | 1,292.45 | 1,154.39 | 1,019.99 | |
| CURRENT ASSETS | ||||||
| Current Investments | 283.48 | 172.48 | 42.76 | 86.52 | 125.99 | |
| Inventories | 781.15 | 694.51 | 697.09 | 393.12 | 342.83 | |
| Trade Receivables | 1,194.00 | 1,317.43 | 831.27 | 409.61 | 340.01 | |
| Cash And Cash Equivalents | 69.68 | 218.49 | 277.76 | 366.69 | 265.33 | |
| Short Term Loans And Advances | 103.41 | 80.88 | 68.32 | 62.96 | 38.79 | |
| OtherCurrentAssets | 299.91 | 188.54 | 145.66 | 105.08 | 88.80 | |
| Total Current Assets | 2,731.63 | 2,672.33 | 2,062.86 | 1,423.99 | 1,201.75 | |
| Total Assets | 6,509.59 | 4,332.68 | 3,355.31 | 2,578.38 | 2,221.74 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 745.24 | 215.56 | 338.52 | 54.24 | 52.47 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 225.95 | 252.92 | 214.18 | 194.55 | 192.39 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 39.49 | 74.68 | 22.02 | 20.57 | 29.76 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 238.36 | 182.41 | 230.13 | 133.92 | 93.17 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | 0.10 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 1,413.59 | 1,566.48 | 1,211.43 | 758.54 | 578.18 | |
| Other Earnings | 52.35 | 119.76 | 111.39 | 56.48 | 29.88 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 77.80 | 77.80 | 35.49 | 35.49 | 35.49 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 150.35 | 149.38 | 147.50 | 391.30 | 304.53 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | 283.48 | 172.48 | 42.76 | 86.52 | 125.99 |
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012